<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02612792</url>
  </required_header>
  <id_info>
    <org_study_id>GDCRI/ACM/PG/PhD/2/2013-2014U</org_study_id>
    <nct_id>NCT02612792</nct_id>
  </id_info>
  <brief_title>Platelet Rich Fibrin+1.2% Atorvastatin in Treatment of Mandibular Degree II Furcation Defects</brief_title>
  <official_title>Platelet Rich Fibrin Combined With 1.2% Atorvastatin Gel in Treatment of Mandibular Degree II Furcation Defects: a Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Government Dental College and Research Institute, Bangalore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Government Dental College and Research Institute, Bangalore</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study was designed to explore the effectiveness of PRF combined with 1.2% ATV gel&#xD;
      in treatment of mandibular degree II furcation defects in comparison to PRF and open flap&#xD;
      debridement (OFD) alone.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: A variety of regenerative materials have been tried since many years for the&#xD;
      treatment of furcation defects. Platelet-rich fibrin (PRF), a pool reservoir of platelet&#xD;
      concentrate with growth factors and Atorvastatin (ATV), a potent member of statin group are&#xD;
      known to promote periodontal tissue regeneration. The aim of the present study is to explore&#xD;
      the effectiveness of PRF combined with 1.2% ATV gel in treatment of mandibular degree II&#xD;
      furcation defects in comparison to PRF and open flap debridement (OFD) alone.&#xD;
&#xD;
      Methods: Eighty two mandibular furcation defects were treated with either OFD alone (Group&#xD;
      1), OFD with PRF (Group 2), and OFD with PRF+1.2% ATV gel (Group 3).Clinical parameters like&#xD;
      probing depth (PD), relative vertical clinical attachment level (RVCAL), relative horizontal&#xD;
      clinical attachment level (RHCAL), modified sulcus bleeding index (mSBI) and site specific&#xD;
      plaque index (PI) were recorded at baseline and 9 months post-operatively. The radiological&#xD;
      assessment of bone defect fill was done at baseline and 9 months, using computer-aided&#xD;
      software.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>. Radiographic bone fill assessed in percentage</measure>
    <time_frame>baseline to 9 months</time_frame>
    <description>assessed in percentage</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>probing depth measured in mm</measure>
    <time_frame>baseline to 9 months</time_frame>
    <description>measured in mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relative vertical attachment level measured in mm</measure>
    <time_frame>baseline to 9 months</time_frame>
    <description>measured in mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relative horizontal attachment level measured in mm</measure>
    <time_frame>baseline to 9 months</time_frame>
    <description>measured in mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>modified sulcus bleeding index</measure>
    <time_frame>baseline to 9 months</time_frame>
    <description>0-3 scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>plaque index</measure>
    <time_frame>baseline to 9 months</time_frame>
    <description>0-3 scale</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">82</enrollment>
  <condition>Furcation Defects</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Scaling and Root Planing (SRP) with Open flap debridement (OFD) alone for treating furcation defect</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>SRP with Open flap debridement (OFD) with Platelet rich fibrin (PRF) for treating furcation defect</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>SRP with Open flap debridement (OFD) with Platelet rich fibrin (PRF)+1.2% Atorvastatin for treating furcation defect</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open flap debridement (OFD)</intervention_name>
    <description>Open flap debridement (OFD) alone</description>
    <arm_group_label>Group 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>OFD with Platelet rich fibrin (PRF)</intervention_name>
    <description>Open flap debridement (OFD) with Platelet rich fibrin (PRF) placement</description>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>OFD with Platelet rich fibrin (PRF)+1.2% Atorvastatin (Drug) in gel form</intervention_name>
    <description>Open flap debridement (OFD) with Platelet rich fibrin (PRF)+1.2% Atorvastatin gel placement</description>
    <arm_group_label>Group 3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Buccal degree II furcation defects in endodontically vital, asymptomatic mandibular&#xD;
             first and second molars with a radiolucency in the furcation area on an intraoral&#xD;
             periapical radiograph with probing depth (PD) ≥ 5mm and horizontal ≥ PD 3mm after&#xD;
             phase I therapy i.e, scaling and root planing (SRP);&#xD;
&#xD;
          -  No history of antibiotic or periodontal therapy in the preceding 6 months.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Aggressive periodontitis patients&#xD;
&#xD;
          -  Systemic conditions known to affect the periodontal status;&#xD;
&#xD;
          -  Medications known to affect the outcomes of periodontal therapy;&#xD;
&#xD;
          -  Hematological disorders and insufficient platelet count (&lt;100,000/mm3);&#xD;
&#xD;
          -  Pregnancy/lactation;&#xD;
&#xD;
          -  Smoking and tobacco use in any form&#xD;
&#xD;
          -  Immunocompromised individuals;&#xD;
&#xD;
          -  Those having unacceptable oral hygiene (plaque index [PI] &gt;1.5).&#xD;
&#xD;
          -  Teeth with furcation involvement, non-vital teeth, and carious teeth indicated for&#xD;
             restorations and mobility of at least grade II were also excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Government Dental College and Research Institute</name>
      <address>
        <city>Bangalore</city>
        <state>Karnataka</state>
        <zip>560002</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <study_first_submitted>November 20, 2015</study_first_submitted>
  <study_first_submitted_qc>November 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 24, 2015</study_first_posted>
  <last_update_submitted>November 23, 2015</last_update_submitted>
  <last_update_submitted_qc>November 23, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 24, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Government Dental College and Research Institute, Bangalore</investigator_affiliation>
    <investigator_full_name>Dr. A R Pradeep</investigator_full_name>
    <investigator_title>Professor and Head, Dept of Periodontology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Furcation Defects</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atorvastatin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

